PT  - JOURNAL ARTICLE
AU  - Travis M. Howard
AU  - Umesh N. Khot
TI  - Dual antiplatelet therapy after percutaneous coronary intervention: Personalize the duration
AID  - 10.3949/ccjm.88a.20113
DP  - 2021 Jun 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 325--332
VI  - 88
IP  - 6
4099  - http://www.ccjm.org/content/88/6/325.short
4100  - http://www.ccjm.org/content/88/6/325.full
SO  - Cleve Clin J Med2021 Jun 01; 88
AB  - The recommended duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention with a drug-eluting stent has changed from 1 year for all to a more personalized approach based on the patient’s risks of ischemia and bleeding. The trend is toward shorter treatment in view of lower rates of late and very late stent thrombosis with newer drug-eluting stents and the risk of bleeding with DAPT. But some patients at high risk of ischemic events and low risk of bleeding may benefit from longer treatment.